ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 680

$857K Total Retail Price of All Prescriptions

Rank: 117 out of 680

633 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 633 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,512 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
OMEPRAZOLE 385 314 1 7
HYDROCODONE-ACETAMINOPHEN 338 267 S3 2 4
LEVOTHYROXINE SODIUM 328 274 3 2
AMLODIPINE BESYLATE 319 269 4 1
SIMVASTATIN 318 274 5 3
QUETIAPINE FUMARATE 277 233 6 64
FUROSEMIDE 271 221 7 6
METOPROLOL TARTRATE 255 184 8 12
METOPROLOL SUCCINATE 251 217 9 13
DONEPEZIL HCL 229 228 10 27
LISINOPRIL 208 183 11 5
TRAMADOL HCL 203 156 12 18
PRAVASTATIN SODIUM 186 153 13 10
ZOLPIDEM TARTRATE 181 147 14 17
NAMENDA 180 168 15 35
ESCITALOPRAM OXALATE 177 173 16 45
CLONIDINE HCL 172 139 17 36
CARVEDILOL 171 127 18 23
ATORVASTATIN CALCIUM 167 150 19 11
CYMBALTA 166 154 20 46
NEXIUM 163 108 21 16
LACTULOSE 159 137 22 92
OLANZAPINE 158 130 23 116
GABAPENTIN 155 146 24 15
PANTOPRAZOLE SODIUM 155 114 24 30
IPRATROPIUM BROMIDE 154 79 26 211
METFORMIN HCL 151 98 27 8
WARFARIN SODIUM 150 135 28 20
NIFEDIPINE ER 150 126 28 75
CITALOPRAM HBR 149 118 30 22
ALBUTEROL SULFATE 144 82 31 154
LEVETIRACETAM 141 80 32 120
AZITHROMYCIN 135 97 33 42
TAMSULOSIN HCL 133 109 34 34
POTASSIUM CHLORIDE 132 115 35 14
MELOXICAM 124 98 36 24
DIGOXIN 117 93 37 58
LEVEMIR FLEXPEN 114 85 38 186
LANTUS 114 68 38 49
HYDRALAZINE HCL 113 86 40 71
HYDROCHLOROTHIAZIDE 110 79 41 9
CLOPIDOGREL 108 104 42 26
RISPERIDONE 99 86 43 80
SERTRALINE HCL 96 77 44 28
MIRTAZAPINE 95 93 45 78
OXYBUTYNIN CHLORIDE 93 93 46 129
ADVAIR DISKUS 90 73 47 53
SEROQUEL 86 69 48 123
DIOVAN HCT 84 69 49 55
LEVOFLOXACIN 82 61 50 97
POLYETHYLENE GLYCOL 3350 82 71 50 62
EXELON 82 82 50 112
NOVOLOG FLEXPEN 82 64 50 189
AMIODARONE HCL 79 67 54 158
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 53 55 37
GLYBURIDE-METFORMIN HCL 77 71 R 55 107
ALLOPURINOL 77 58 55 33
ONGLYZA 76 55 58 136
DIVALPROEX SODIUM 75 59 59 110
NOVOFINE AUTOCOVER 74 67 60 248
MEGESTROL ACETATE 73 51 R 61 88
ISOSORBIDE MONONITRATE ER 73 62 61 59
SANTYL 69 53 63 170
METHYLPREDNISOLONE 69 51 63 93
ALENDRONATE SODIUM 66 60 65 32
CARAFATE 62 48 66 273
GLIMEPIRIDE 62 55 66 29
CARBIDOPA-LEVODOPA 62 62 66 117
CRESTOR 60 57 69 25
PAROXETINE HCL 59 49 70 76
CIPROFLOXACIN HCL 58 52 71 57
DIVALPROEX SODIUM ER 57 51 72 148
SUCRALFATE 56 45 73 160
LIPITOR 55 47 74 68
JANUVIA 55 28 74 60
DOXAZOSIN MESYLATE 55 55 74 73
PLAVIX 55 53 74 39
AGGRENOX 53 52 78 177
CILOSTAZOL 53 50 78 230
ROPINIROLE HCL 51 51 80 99
PREDNISONE 51 44 80 50
FLUOXETINE HCL 50 44 82 74
CYCLOBENZAPRINE HCL 50 22 R 82 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.